Tamar Ben-Yedidia

Tamar Ben-Yedidia is the CSO at BiondVax Pharmaceuticals. Tamar was previously a professor assistant at the Weizmann Institute of Science from March 2000 to March 2005. Before that, they were the R&D Lab manager at Biotechnology general (BTG) from January 1988 to December 1993. Tamar managed a lab that developed a cell based Hepatitis B vaccine, optimizing the production and developed assays. The vaccine is currently on the market.

Tamar Ben-Yedidia has a Doctor of Philosophy (Ph.D.) in Immunology from Weizmann Institute of Science and a MSc in Immunology from Tel Aviv University.

Some of their coworkers include Uri Ben-Or - CFO, Elad Mark - Chief Operating Officer, and Shimon Hassin - Chief Administrative Officer. Tamar Ben-Yedidia reports to Ron Babecoff, Founder, President & CEO .